Arlouskaya, Y.; Sawicka, A.; Głowala, M.; Giebułtowicz, J.; Korytowska, N.; Tałałaj, M.; Nowicka, G.; Wrzosek, M.
Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA) Concentrations in Patients with Obesity and the Risk of Obstructive Sleep Apnea (OSA). J. Clin. Med. 2019, 8, 897.
https://doi.org/10.3390/jcm8060897
AMA Style
Arlouskaya Y, Sawicka A, Głowala M, Giebułtowicz J, Korytowska N, Tałałaj M, Nowicka G, Wrzosek M.
Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA) Concentrations in Patients with Obesity and the Risk of Obstructive Sleep Apnea (OSA). Journal of Clinical Medicine. 2019; 8(6):897.
https://doi.org/10.3390/jcm8060897
Chicago/Turabian Style
Arlouskaya, Yana, Ada Sawicka, Marek Głowala, Joanna Giebułtowicz, Natalia Korytowska, Marek Tałałaj, Grażyna Nowicka, and Małgorzata Wrzosek.
2019. "Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA) Concentrations in Patients with Obesity and the Risk of Obstructive Sleep Apnea (OSA)" Journal of Clinical Medicine 8, no. 6: 897.
https://doi.org/10.3390/jcm8060897
APA Style
Arlouskaya, Y., Sawicka, A., Głowala, M., Giebułtowicz, J., Korytowska, N., Tałałaj, M., Nowicka, G., & Wrzosek, M.
(2019). Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA) Concentrations in Patients with Obesity and the Risk of Obstructive Sleep Apnea (OSA). Journal of Clinical Medicine, 8(6), 897.
https://doi.org/10.3390/jcm8060897
